Altered body composition in male long-term survivors of paediatric allogeneic haematopoietic stem cell transplantation: impact of conditioning regimen, chronic graft-versus-host disease and hypogonadism

被引:12
|
作者
Mejdahl Nielsen, Malene [1 ]
Mathiesen, Sidsel [1 ]
Suominen, Anu [2 ,3 ]
Sorensen, Kaspar [1 ]
Ifversen, Marianne [1 ]
Molgaard, Christian [4 ,5 ]
Lahteenmaki, Paivi M. [6 ,7 ]
Juul, Anders [8 ]
Jahnukainen, Kirsi [2 ,3 ,9 ,10 ]
Mueller, Klaus [1 ,11 ,12 ]
机构
[1] Univ Copenhagen, Rigshosp, Dept Paediat & Adolescent Med, Copenhagen, Denmark
[2] Univ Helsinki, Div Haematol Oncol & Stem Cell Transplantat, Childrens Hosp, Helsinki, Finland
[3] Helsinki Univ Cent Hosp, Helsinki, Finland
[4] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark
[5] Univ Copenhagen, Rigshosp, Paediat Nutr Unit, Copenhagen, Denmark
[6] Turku Univ Hosp, Dept Paediat & Adolescent Med, Turku, Finland
[7] Turku Univ, Turku, Finland
[8] Univ Copenhagen, Rigshosp, Dept Growth & Reprod, Copenhagen, Denmark
[9] Karolinska Inst, Paediat Endocrinol Unit, Dept Womens & Childrens Hlth, Karolinska Inst, Stockholm, Sweden
[10] Univ Hosp, Stockholm, Sweden
[11] Univ Copenhagen, Rigshosp, Inst Inflammat Res, Copenhagen, Denmark
[12] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark
基金
瑞典研究理事会;
关键词
MASS; HEALTH;
D O I
10.1038/s41409-020-01038-3
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Changes in body composition related to metabolic syndrome are frequent among survivors of haematopoietic stem cell transplantation (HSCT), but insights into predisposing factors are incomplete, and it is unknown to what degree these changes persist at long term. We cross-sectionally investigated body composition by dual-energy X-ray absorptiometry in 98 male survivors of paediatric allogeneic HSCT. Median (range) age at follow-up was 28.1 (18.5-47.0) years and median (range) time from transplant was 18.3 (7.7-34.6) years. Lean Body Mass Index and Skeletal Muscle Mass Index were lower in patients compared to the reference population (mean (SD) standard deviation score (SDS) -1.29 (0.99), p < 0.001 and -1.20 (1.03), p < 0.001). Fat Mass Index was comparable to the reference population, but android/gynoid (AG) fat ratio SDS was higher (mean (SD) 0.46 (1.28), p < 0.001). These changes were found in patients treated with total body irradiation (TBI) as well as non-TBI regimens, although most pronounced in the former. Further, low lean mass was associated with chronic graft-versus-host disease, while high AG ratio was associated with lower testosterone levels. Since the combination of low lean mass and high AG ratio increases the risk of cardio-metabolic disease, these health issues should be monitored at long-term clinical follow-up after paediatric HSCT.
引用
收藏
页码:457 / 460
页数:4
相关论文
共 50 条
  • [21] CERVICAL CYTOLOGY SCREENING IN LONG-TERM SURVIVORS OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH GENITAL GRAFT VERSUS HOST DISEASE
    Shanis, D. L.
    Pophali, P.
    Koklanaris, E.
    Battiwalla, M.
    Barrett, J.
    Stratton, P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S282 - S282
  • [22] A case of tongue carcinoma associated with chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
    Noguchi, K.
    Nakase, M.
    Inui, M.
    Nakamura, S.
    Okumura, K.
    Tagawa, T.
    AUSTRALIAN DENTAL JOURNAL, 2010, 55 (02) : 200 - 202
  • [23] Incidence of and risk factors for chronic graft-versus-host disease in children given an allogeneic haematopoietic stem cell transplantation
    Zecca, M
    Pession, A
    Rondelli, R
    Lanino, E
    Uderzo, C
    Messina, C
    Fagioli, F
    Porta, F
    Locatelli, F
    Prete, A
    BONE MARROW TRANSPLANTATION, 2001, 27 : S5 - S5
  • [24] Chronic Graft-Versus-Host Disease in Long-Term Survivors of Childhood Leukemia
    Saultier, Paul
    Michel, Gerard
    Sirvent, Anne
    Halfon-Domenech, Carine
    Tabone, Marie-Dominique
    Leverger, Guy
    Baruchel, Andre
    Pochon, Cecile
    Paillard, Catherine
    Ducassou, Stephane
    Poiree, Marilyne
    Plantaz, Dominique
    Kanold, Justyna
    Gandemer, Virginie
    Sirvent, Nicolas
    Raus, Nicole
    Thouvenin, Sandrine
    Berbis, Julie
    Auquier, Pascal
    Dalle, Jean-Hugues
    BLOOD, 2023, 142
  • [25] Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation
    Stratton, Pamela
    Turner, Maria L.
    Childs, Richard
    Barrett, John
    Bishop, Michael
    Wayne, Alan S.
    Pavletic, Steven
    OBSTETRICS AND GYNECOLOGY, 2007, 110 (05): : 1041 - 1049
  • [26] Chronic graft-versus-host disease after allogeneic blood stem cell transplantation
    Przepiorka, D
    Anderlini, P
    Saliba, R
    Cleary, K
    Mehra, R
    Khouri, I
    Huh, YO
    Giralt, S
    Braunschweig, I
    van Besien, K
    Champlin, R
    BLOOD, 2001, 98 (06) : 1695 - 1700
  • [27] Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
    Anna Cäcilia Ingham
    Katrine Kielsen
    Hanne Mordhorst
    Marianne Ifversen
    Frank M. Aarestrup
    Klaus Gottlob Müller
    Sünje Johanna Pamp
    Microbiome, 9
  • [28] Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation
    Ingham, Anna Cacilia
    Kielsen, Katrine
    Mordhorst, Hanne
    Ifversen, Marianne
    Aarestrup, Frank M.
    Mueller, Klaus Gottlob
    Pamp, Sunje Johanna
    MICROBIOME, 2021, 9 (01)
  • [29] Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation
    Messina, C
    Locatelli, F
    Lanino, E
    Uderzo, C
    Zacchello, G
    Cesaro, S
    Pillon, M
    Perotti, C
    Del Fante, C
    Faraci, M
    Rivabella, L
    Calore, E
    De Stefano, P
    Zecca, M
    Giorgiani, G
    Brugiolo, A
    Balduzzi, A
    Dini, G
    Zanesco, L
    Dall'Amico, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (01) : 118 - 127
  • [30] HLA allele associations with graft-versus-host disease following allogeneic haematopoietic stem cell transplantation
    Kitra, V
    Moraloglou, O
    Petra, F
    Spanou, K
    Peristeri, I
    Gousetis, E
    Delikou, S
    Constantinidou, N
    Graphakos, S
    BONE MARROW TRANSPLANTATION, 2005, 35 : S137 - S138